These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 407891)

  • 21. [Comparative study of the medium term use of verapamil and perhexiline in the treatment of chronic coronary insufficiency. Clinical and cycloergometric evaluation].
    Candau LA; Padilha JC; Tasca R; de Patta M; Weiskopf JS; Scherr C
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():51-62. PubMed ID: 678165
    [No Abstract]   [Full Text] [Related]  

  • 22. Myocardiocyte apoptosis in heart failure in chronic Chagas' disease.
    Tostes S; Bertulucci Rocha-Rodrigues D; de Araujo Pereira G; Rodrigues V
    Int J Cardiol; 2005 Mar; 99(2):233-7. PubMed ID: 15749181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cross double-blind study with verapamil x placebo in ischemic heart disease with an ergometric test].
    Ribeiro JM; Sadi J; Barros FA
    Arq Bras Cardiol; 1984 Aug; 43(2):139-42. PubMed ID: 6398044
    [No Abstract]   [Full Text] [Related]  

  • 24. [Electrocardiographic study of the site of origin of ventricular extrasystoles in chronic Chagas' heart disease].
    Moriera AC; Freitas OC; Netto AR; Vichi FL
    Arq Bras Cardiol; 1972 Apr; 25(2):141-5. PubMed ID: 4625904
    [No Abstract]   [Full Text] [Related]  

  • 25. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment.
    Almeida DR; Carvalho AC; Branco JN; Pereira AP; Correa L; Vianna PV; Buffolo E; Martinez EE
    J Heart Lung Transplant; 1996 Oct; 15(10):988-92. PubMed ID: 8913915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phonomechanocardiographic evaluation of the effect of inosine on the function of the left ventricle in patients with chronic coronary insufficiency].
    Ortiz J; Winter HE; Barreto AC; Tranchesi J; Pileggi F; Rangel FA; Del Nero E
    Arq Bras Cardiol; 1975 Jun; 28(3):361-7. PubMed ID: 1180717
    [No Abstract]   [Full Text] [Related]  

  • 27. [Symptomatic management of Chagas' heart disease using a beta-adrenergic blocking agent].
    Luquez HA; Madoery R; Amuchastegui SR; Patrignani JA
    Prensa Med Argent; 1968 Jun; 55(17):774-8. PubMed ID: 4976177
    [No Abstract]   [Full Text] [Related]  

  • 28. [Electrocardiographic and hemodynamic disorders induced by verapamil: experimental study].
    Belardinelli L; Sant'Anna JR; Mattos E; Wagner EM; Lucchese FA
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():31-6. PubMed ID: 329806
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of verapamil in coronariopathic patients. Evaluation using the ergometric test].
    Duarte GM; Ribeiro LG; Coelho W; Thevenard R; Souza PJ; Gonçalves MA; Carneiro RD; Luna RL
    Arq Bras Cardiol; 1976 Aug; 29(4):338-45. PubMed ID: 1008726
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of intravenous infusion of xylocaine on the extrasystole of chronic Chagasic cardiopathy].
    Vichi FL; Campos IB; Romero LC; Tukiyama A
    Rev Paul Med; 1972 Sep; 80(3):133-6. PubMed ID: 4135966
    [No Abstract]   [Full Text] [Related]  

  • 31. [Parasympathetic denervation and myocardial hypertrophy in chronic Chagas' disease].
    Chapadeiro E; Lopes ER; Pereira FE
    Rev Inst Med Trop Sao Paulo; 1967; 9(1):40-2. PubMed ID: 4970707
    [No Abstract]   [Full Text] [Related]  

  • 32. [Coronary disease. Clinical experience with a new active substance combination].
    Bouzo H
    Med Welt; 1977 Dec; 28(49):2001-7. PubMed ID: 340839
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of verapamil in the treatment of idiopathic cardiac hypertrophy].
    Sekeff JA; Perez VP; Freitas LB; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():49-54. PubMed ID: 142464
    [No Abstract]   [Full Text] [Related]  

  • 34. [The use of verapamil in suppositories for treating patients with ischemic heart disease].
    Shkliar MB; Soleĭko MB; Alekseeva IP; Kul'chevich LV
    Vrach Delo; 1990 Aug; (8):13-5. PubMed ID: 2256273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combined action of anti-arrhythmia agents in the cardiology clinic].
    Zabela PV
    Farmakol Toksikol; 1986; 49(5):62-3. PubMed ID: 3770178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Supraventricular paroxysmal tachycardia with aberrant conduction in a patient with Chagas' disease. Report of a case].
    Mello DC; Alencar SM; Trigueiros JC; Carvalho S; Cavalcante E; Albuquerque C; Loureiro FB
    Arq Bras Cardiol; 1977 Jun; 30(3):217-20. PubMed ID: 411460
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the effect of verapamil on the tolerance for exertion in coronary patients].
    Miraglia G; Stritoni P; Egloff C; Scattolin G; Contessotto F; Passarin N; Dalla Volta S
    Boll Soc Ital Cardiol; 1979; 24(5):583-9. PubMed ID: 553643
    [No Abstract]   [Full Text] [Related]  

  • 38. [Emboligenic myocardiopathy in Chagas' disease].
    Castagnino HE; Cicco JA; Fauth M; Thompson AC
    Medicina (B Aires); 1978; 38(1):35-9. PubMed ID: 101735
    [No Abstract]   [Full Text] [Related]  

  • 39. [Systolic quotient of the left ventricle in the chronic form of Chagas' disease].
    Del Nero Júnior E; Pereira Barretto AC; Ortiz J; de Assis Rangel F; Diament J; Papaléo Netto M; Tranchesi J; Gastão do Serro-Azul L
    Rev Hosp Clin Fac Med Sao Paulo; 1975 Aug; 30(4 Suppl):281-5. PubMed ID: 806955
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cardiopathy in Americana trypanosomiasis (Chagas' disease)].
    Kireev PM
    Klin Med (Mosk); 1975 May; 52(5):34-7. PubMed ID: 805880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.